Healthcare investors are often faced with a choice between companies that generate steady growth across diversified ...

Thermo Fisher’s (NYSE:TMO) latest guidance increase also raises the bar for future execution. With improving organic growth ...

Healthcare investors often face a difficult decision when choosing between companies with very different paths to growth.

Healthcare investors are beginning to see signs of recovery across several parts of the industry, but not every recovery ...

Gilead Sciences, Inc. (NASDAQ:GILD) delivered its strongest commercial momentum in several years during fiscal Q2 2026, with ...

AstraZeneca PLC (NYSE:AZN) is paying $600 million upfront to secure global rights to Zegfrovy from Dizal Pharmaceutical Co., ...

Zoetis Inc. (NYSE:ZTS) entered 2026 as a leader in animal health, but its latest earnings show that even a strong market ...

Medtronic plc (NYSE:MDT) and Tenet Healthcare Corporation (NYSE:THC) offer investors two very different healthcare growth ...

The next few years will test whether Pfizer Inc. (NYSE:PFE) can replace yesterday’s blockbusters, and whether Gilead Sciences ...

Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher’s (NYSE:TMO) ...

Marvell and Google signed an expanded commercial agreement on July 29 to develop custom artificial intelligence silicon.

Insider Monkey’s investor database shows several prominent growth investors converging on a relatively obscure AI ...